BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30898658)

  • 21. Bilateral salpingectomy as an option of permanent contraception at time of caesarean section: A survey of practice.
    Noori N; Edwards L; Anpalagan A; Athavale R; Burling M; Herbst U; Brand A; Kapurubandara S
    Aust N Z J Obstet Gynaecol; 2024 Feb; 64(1):72-76. PubMed ID: 37674327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
    Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
    Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contraception and sterilization selection at delivery among pregnant patients with malignancy.
    Harris CA; Mandelbaum RS; Rau AR; Song BB; Klar M; Ouzounian JG; Paulson RJ; Roman LD; Matsuo K
    Acta Obstet Gynecol Scand; 2024 Apr; 103(4):695-706. PubMed ID: 37578024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A low-cost approach to salpingectomy at cesarean delivery.
    Guo XM; Hall EF; Mazzullo L; Djordjevic M
    Am J Obstet Gynecol; 2020 May; 222(5):503.e1-503.e3. PubMed ID: 31981512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian reserve following cesarean section with salpingectomy vs tubal ligation: a randomized trial.
    Ganer Herman H; Gluck O; Keidar R; Kerner R; Kovo M; Levran D; Bar J; Sagiv R
    Am J Obstet Gynecol; 2017 Oct; 217(4):472.e1-472.e6. PubMed ID: 28455082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete Compared With Partial Salpingectomy for Postpartum Sterilization.
    McCarley CB; Boitano TK; Dilley SE; Subramaniam A
    Obstet Gynecol; 2023 Dec; 142(6):1347-1356. PubMed ID: 37884007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Trend, Feasibility, and Safety of Salpingectomy as a form of Permanent Sterilization.
    Kim AJ; Barberio A; Berens P; Chen HY; Gants S; Swilinski L; Acholonu U; Chang-Jackson SC
    J Minim Invasive Gynecol; 2019; 26(7):1363-1368. PubMed ID: 30771489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risks and Benefits of Salpingectomy at the Time of Sterilization.
    Castellano T; Zerden M; Marsh L; Boggess K
    Obstet Gynecol Surv; 2017 Nov; 72(11):663-668. PubMed ID: 29164264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Opportunistic Bilateral Salpingectomy vs Tubal Occlusion or Ligation for Ovarian Cancer Prophylaxis.
    Ely LK; Truong M
    J Minim Invasive Gynecol; 2017; 24(3):371-378. PubMed ID: 28087480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial Disparities in Sterilization Procedure Performed at Time of Cesarean Section.
    Walheim LK; Hong CX; Hamm RF
    Am J Perinatol; 2024 May; 41(S 01):e934-e938. PubMed ID: 36351447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective cohort study of tubal occlusion or salpingectomy for permanent contraception in Australia.
    Baltus T; Brown J; Kapurubandara S
    Aust N Z J Obstet Gynaecol; 2022 Apr; 62(2):312-318. PubMed ID: 34705269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
    Hanley GE; McAlpine JN; Pearce CL; Miller D
    Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
    Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
    Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction.
    Subramaniam A; Einerson BD; Blanchard CT; Erickson BK; Szychowski J; Leath CA; Biggio JR; Huh WK
    Gynecol Oncol; 2019 Jan; 152(1):127-132. PubMed ID: 30477808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sterilization at the time of cesarean section: tubal ligation or hysterectomy?
    Bukovsky I; Schneider D; Weinraub Z; Arieli S; Schreyer P; Caspi E
    Contraception; 1983 Oct; 28(4):349-56. PubMed ID: 6667624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of salpingectomy at time of delivery.
    Parikh P; Kim S; Hathcock M; Torbenson VE; Raju R
    J Matern Fetal Neonatal Med; 2021 Sep; 34(17):2765-2770. PubMed ID: 31544559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postpartum Salpingectomy Compared With Standard Tubal Ligation After Vaginal Delivery.
    Wagar MK; Godecker A; Landeros MV; Williams M
    Obstet Gynecol; 2021 Mar; 137(3):514-520. PubMed ID: 33595245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients' perceptions toward and the driving factors of decision-making for opportunistic bilateral salpingectomy at the time of cesarean section.
    Yassa M; Pulatoğlu Ç
    Turk J Obstet Gynecol; 2020 Jun; 17(2):115-122. PubMed ID: 32850186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Techniques for the interruption of tubal patency for female sterilisation.
    Lawrie TA; Kulier R; Nardin JM
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD003034. PubMed ID: 27494193
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.